HopeStage
Back to all studies
UnknownNCT05826327

Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression in Parturients

Medication studyAges 18+China
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
HangzhouSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 1, 2023
Recruitment status
Unknown
Enrollment listed in the registry
364
Sponsor
Women's Hospital School Of Medicine Zhejiang University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
China
Age range
Over 18 Years
Official registry ID
NCT05826327
Official title
Show the full official title

Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression and Maternal and Neonatal Outcomes in Parturients With Prenatal Depression

Recruitment & locations

Status unknown

Hangzhou

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Women's Hospital School Of Medicine Zhejiang University, a university.

Does this study involve medication?

Yes. The study involves medication, including Esketamine and Sufentanil.

Who can participate?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies